港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

科倫博泰生物-B

416.600

+4.0000.97%

成交量：9.55萬

成交額：3,963.21萬

市值：971.45億

市盈率：-346.14

高：419.800

開：410.400

低：407.600

收：412.600

52周最高：581.000

52周最低：183.100

股本：2.33億

香港流通股本：1.63億

量比：0.23

換手率：0.06%

股息：- -

股息率：- -

每股收益(LYR):-1.204

淨資產收益率：-17.56%

總資產收益率：-9.92%

市淨率：17.11

市盈率(LYR):-346.14

市銷率: 57.18

資料載入中...

總覽公司新聞資訊公告

BUZZ-癌症新藥全球試驗啓動，新月生物製藥股價上漲

每日沽空追蹤 | 科倫博泰生物-B 02月16日沽空量成交9800股，沽空比例為32.98%

科倫博泰生物-B逆勢下跌3.33%，受板塊走弱及機構觀點分歧影響

经济观察网

每日沽空追蹤 | 科倫博泰生物-B 02月11日沽空量成交5.74萬股，沽空比例為11.86%

科倫博泰生物-B02月11日主力淨流入282.1萬元散户資金拋售

中金：維持科倫博泰生物-B(06990)跑贏行業評級目標價550港元

恒生醫療保健指數升2.17% 醫藥板塊普遍拉升機構持續看好中國創新藥出海的產業趨勢

醫藥生物行業研究：驅動基因陰性NSCLC專題：下一代治療範式：雙抗、IO+ADC

科倫博泰重磅藥物，獲批新適應症！

科倫博泰生物-B宣佈薩坦珠單抗（Sac-TMT）獲NMPA批准用於HR+/HER2-乳腺癌，為第四項適應症

科倫博泰生物-B(06990)：核心產品TROP2ADC蘆康沙妥珠單抗(sac-TMT)獲國家藥品監督管理局批准第四項適應症上市，用於治療2L+HR+/HER2-乳腺癌

科倫博泰生物-B：Trop2 ADC藥物Sacituzumab Tirumotecan獲NMPA批准上市，適應症擴展至第四項

創新藥板塊走高諾誠健華(09969)漲10.98% 國家藥監局：「十五五」大力支持生物製造產業創新發展

四川科倫博泰生物醫藥（06990）更新2026年1月股份變動月報表，股本維持穩定

每日沽空追蹤 | 科倫博泰生物-B 02月04日沽空量成交2.89萬股，沽空比例為5.39%

科倫博泰生物-B02月04日獲主力加倉196.7萬元

科倫博泰生物-B02月03日獲主力加倉264.8萬元

醫藥行業跟蹤報告：MNC重金加碼中國創新藥，中國IO2.0雙抗出海邁出關鍵一步

每日沽空追蹤 | 科倫博泰生物-B 02月02日沽空量成交4.45萬股，沽空比例為8.48%

百濟神州 ≈ 信達生物+科倫博泰+康方生物？

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":416.6,"timestamp":1771574918009,"preClose":412.6,"halted":0,"volume":95500,"delay":0,"changeRate":0.009694619486185167,"floatShares":162769979,"shares":233185969,"eps":-1.203559,"marketStatus":"未開盤","change":4,"latestTime":"02-20 16:08:38","open":410.4,"high":419.8,"low":407.6,"amount":39632120,"amplitude":0.029569,"askPrice":416.6,"askSize":6300,"bidPrice":415.6,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.508831,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":412.6,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":0.22509739500416204,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":162769979,"roa":"-9.92%","roe":"-17.56%","lyrEps":-1.203559,"volumeRatio":0.22509739500416204,"shares":233185969,"dividePrice":0,"high":419.8,"amplitude":0.029569,"preClose":412.6,"low":407.6,"week52Low":183.1,"pbRate":"17.11","psRate":"57.18","week52High":581,"institutionHeld":0,"latestPrice":416.6,"committee":-0.909091,"eps":-1.203559,"divideRate":0,"volume":95500,"delay":0,"ttmEps":-3.508831,"open":410.4,"prevYearClose":392.2,"prevWeekClose":418.6,"prevMonthClose":415.4,"prevQuarterClose":392.2,"fiveDayClose":437.2,"twentyDayClose":442.4,"sixtyDayClose":439.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3684,"buy":0.5263,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1764777600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-02-20","current":-118.729001,"percent":0.551938,"low":-351.800852,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"high":-21.029201,"avg":-126.654771,"sd":78.01089,"marketCap":97145274685},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685}],"updateTime":1771737578987},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612373440","title":"BUZZ-癌症新藥全球試驗啓動，新月生物製藥股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2612373440","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612373440?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 01:04","pubTimestamp":1771434254,"startTime":"0","endTime":"0","summary":"BUZZ-癌症新药全球试验启动，新月生物制药股价上涨2月18日 - ** 新月生物制药 CBIO.O股价上涨4%至9.68美元 ** 该公司称已开始对CR-001进行全球早期试验，以治疗晚期实体瘤** CBIO表示，CR-001是一种实验性癌症药物，旨在帮助免疫系统攻击肿瘤并阻断血液供应** 该公司表示，这项研究将在检查肿瘤缩小的早期迹象之前，测试安全性以及药物在体内的移动和作用情况。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4T3ZE1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","002422","BK0239","BK4139","LU1979443071.USD","CBIO","LU1064131003.USD","BK1161","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","LU0196878994.USD","BK0060"],"gpt_icon":0},{"id":"2612828024","title":"每日沽空追蹤 | 科倫博泰生物-B 02月16日沽空量成交9800股，沽空比例為32.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612828024","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612828024?lang=zh_tw&edition=fundamental","pubTime":"2026-02-16 16:30","pubTimestamp":1771230634,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月16日，跌1.43%，卖空量成交9800股，较上一交易日减少89.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163516a700e050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163516a700e050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2610923012","title":"科倫博泰生物-B逆勢下跌3.33%，受板塊走弱及機構觀點分歧影響","url":"https://stock-news.laohu8.com/highlight/detail?id=2610923012","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610923012?lang=zh_tw&edition=fundamental","pubTime":"2026-02-12 19:14","pubTimestamp":1770894840,"startTime":"0","endTime":"0","summary":"经济观察网 根据2026年2月12日的市场公开信息，科伦博泰生物-B当日逆势下跌3.33%，收报423.40港元，成交额2.08亿港元。其下跌主要受以下因素影响：板块变化情况恒生指数当日下跌0.86%，恒生科技指数跌幅达1.65%，生物技术板块整体下跌0.84%。机构观点美银证券2月12日发布研报，虽将公司目标价从470港元上调至479港元，但重申“中性”评级，并因国家医保目录价格调整下调了Sac-TMT的年度治疗费用假设，将2026年及2027年收入预测分别下调5%及6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-12/doc-inhmqmpx9517434.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-02-12/doc-inhmqmpx9517434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2610967635","title":"每日沽空追蹤 | 科倫博泰生物-B 02月11日沽空量成交5.74萬股，沽空比例為11.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610967635?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 16:30","pubTimestamp":1770798641,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月11日，涨0.18%，卖空量成交5.74万股，较上一交易日减少30.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163607a6ee205e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163607a6ee205e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2610967515","title":"科倫博泰生物-B02月11日主力淨流入282.1萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610967515","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610967515?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 16:15","pubTimestamp":1770797721,"startTime":"0","endTime":"0","summary":"02月11日, 科伦博泰生物-B股价涨0.18%，报收438.00元，成交金额2.1亿元，换手率0.30%，振幅4.76%，量比1.10。科伦博泰生物-B今日主力资金净流入282.1万元，上一交易日主力净流出250.1万元。该股近5个交易日上涨1.70%，主力资金累计净流入626.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流出3078.3万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161617a4971bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211161617a4971bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2610605217","title":"中金：維持科倫博泰生物-B(06990)跑贏行業評級 目標價550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605217?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 09:41","pubTimestamp":1770774116,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，基本维持科伦博泰生物-B2025年/2026年归母净利润预测不变，得益于sac-TMT海外商业化，该行引入2027年归母净利润预测6.3亿元。该行维持跑赢行业评级，基于DCF模型，维持目标价550港元不变，较当前股价有30.0%的上行空间。根据公司披露，在所有乳腺癌病例中HR+/HER2-分子亚型约占70%。目前CDK4/6抑制剂联合内分泌治疗已成为1L标准疗法，但后线选择空间收窄，化疗临床获益有限。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2610268695","title":"恒生醫療保健指數升2.17%  醫藥板塊普遍拉升 機構持續看好中國創新藥出海的產業趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2610268695","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610268695?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 09:59","pubTimestamp":1770688793,"startTime":"0","endTime":"0","summary":"2月8日，信达生物宣布与礼来制药达成战略合作，携手推进肿瘤及免疫领域创新药物的全球研发。2026年，继续看好中国创新药出海的产业趋势，继续重点跟踪ADC、双抗、小核酸、减肥药等核心优势赛道的投资机会，期待JPM大会、ASCO等带来数据更新和BD催化。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974845","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306701.USD","09939","LU1688375341.USD","159506","LU0348825331.USD","LU1720050803.USD","01548","01801","02269","09926","LU0856984785.SGD","01877","LU0634319403.HKD","LU0823426308.USD","LU0181495838.USD","159992","LU0140636845.USD","LU1969619763.USD","LU2045819591.USD","LU1046422090.SGD","LU0417516902.SGD","02696","LU2488822045.USD","09688","02162","LU0502904849.HKD","LU2242644610.SGD","LU0043850808.USD","LU2476274308.USD","02268","BK1587","09995","IE00B5MMRT66.SGD","LU0417516738.SGD","09969","LU0516423174.USD","LU0196878994.USD","03347","LU0051755006.USD","06990","LU1961090484.USD","BK1161","LU2476274720.SGD","LU2039709279.SGD","06978","LU0572944931.SGD","159938","LU0516422366.SGD","LU0359202008.SGD","02359"],"gpt_icon":1},{"id":"2610644763","title":"醫藥生物行業研究：驅動基因陰性NSCLC專題：下一代治療範式：雙抗、IO+ADC","url":"https://stock-news.laohu8.com/highlight/detail?id=2610644763","media":"西南证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610644763?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 00:00","pubTimestamp":1770652800,"startTime":"0","endTime":"0","summary":"驱动基因阴性指肿瘤样本中未检测到明确可靶向的驱动基因突变，分别占中美患者新发NSCLC患者的31%/31%。基于目前中美指南推荐，一线治疗驱动基因阴性NSCLC晚期患者主要依赖PD-1±化疗的治疗方案，我们测算2030年用于驱动基因阴性NSCLC晚期一线治疗的免疫用药中美市场规模分别约为75亿元、180亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210132554a6e8f949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210132554a6e8f949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2609352096","title":"科倫博泰重磅藥物，獲批新適應症！","url":"https://stock-news.laohu8.com/highlight/detail?id=2609352096","media":"药通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609352096?lang=zh_tw&edition=fundamental","pubTime":"2026-02-08 12:06","pubTimestamp":1770523610,"startTime":"0","endTime":"0","summary":"2月6日，NMPA官网显示，科伦博泰TROP2 ADC芦康沙妥珠单抗获批一项新适应症，用于治疗既往接受过内分泌治疗且在晚期或转移性阶段接受过其他系统治疗的不可切除的局部晚期或转移性激素受体阳性（HR+）且人表皮生长因子受体2阴性乳腺癌成人患者。2022年5月，科伦博泰与默沙东签署合作协议，授予后者在大中华区以外的所有地区开发、使用、制造及商业化芦康沙妥珠单抗的独家权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208124748a48a1ddb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260208124748a48a1ddb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"1100448776","title":"科倫博泰生物-B宣佈薩坦珠單抗（Sac-TMT）獲NMPA批准用於HR+/HER2-乳腺癌，為第四項適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=1100448776","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100448776?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 17:04","pubTimestamp":1770368678,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其创新药物萨坦珠单抗已获得国家药品监督管理局批准，用于治疗HR阳性、HER2阴性乳腺癌患者。这是该药物在中国获批的第四项适应症，标志着其在肿瘤治疗领域的应用进一步扩展。此次获批基于临床试验数据，显示萨坦珠单抗在HR+/HER2-乳腺癌患者中表现出显著的疗效和可控的安全性。科伦博泰生物-B持续致力于创新药物的研发与商业化，此次新适应症的获批将有望提升萨坦珠单抗的市场潜力，并为公司未来业绩增长注入动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2609639435","title":"科倫博泰生物-B(06990)：核心產品TROP2ADC蘆康沙妥珠單抗(sac-TMT)獲國家藥品監督管理局批准第四項適應症上市，用於治療2L+HR+/HER2-乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2609639435","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609639435?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 16:36","pubTimestamp":1770366971,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，近日，本公司靶向人滋养细胞表面抗原2的抗体偶联药物芦康沙妥珠单抗(佳泰莱)的一项新增适应症上市申请已获中国国家药品监督管理局批准，用于治疗既往接受过内分泌治疗且在晚期疾病阶段接受过至少一线化疗的不可切除或转移性的激素受体阳性(HR+)且人类表皮生长因子受体2阴性乳腺癌成人患者。此次获批的至少经一线化疗治疗HR+/HER2-BC是芦康沙妥珠单抗在中国上市的第四项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4203","HR","BK4225","BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"1128888972","title":"科倫博泰生物-B：Trop2 ADC藥物Sacituzumab Tirumotecan獲NMPA批准上市，適應症擴展至第四項","url":"https://stock-news.laohu8.com/highlight/detail?id=1128888972","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128888972?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 16:35","pubTimestamp":1770366912,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B宣布，其靶向Trop2的抗体偶联药物（ADC）Sacituzumab Tirumotecan已获得国家药品监督管理局（NMPA）批准上市。这是该药物获批的第四项适应症，标志着其在临床应用范围的进一步扩大。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2609537462","title":"創新藥板塊走高 諾誠健華(09969)漲10.98% 國家藥監局：「十五五」大力支持生物製造產業創新發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2609537462","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609537462?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 11:08","pubTimestamp":1770347330,"startTime":"0","endTime":"0","summary":"消息面上，近日召开的2026年全国药品注册管理和上市后监管工作会议透露，“十五五”期间，国家药监局将大力支持生物制造产业创新发展，推动医药产业由“跟随式创新”向“系统性创新”转型，由“规模速度型增长”向“质量效益型增长”转型，由“传统商业模式”向“供应链数字化”转型。国家药监局相关负责人表示，2025年全年我国共有76个创新药获批上市，研发应用居全球领先水平。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjA5ZTU5M2U3ZjIyNGI4Mzk2MWM1NGUyNWZkZjFmMjE3MzEwNTIzMzcxNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974695","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688428","BK1515","BK1593","02162","BK0239","00867","BK1574","02096","BK1583","09969","SG9999015945.SGD","IE00BMCWC346.EUR","BK1617","LU2488822045.USD","SG9999004220.SGD","BK1587","IE00BGHQDM52.EUR","IE00BYV24P56.USD","BK1141","BK1191","SG9999015978.USD","02228","02157","01672","IE00BVYPNQ40.USD","BK1161","IE00BVYPNP33.GBP","03933","159992","SG9999015952.SGD","SG9999015986.USD","06978","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"1109931140","title":"四川科倫博泰生物醫藥（06990）更新2026年1月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109931140","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109931140?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 16:43","pubTimestamp":1770194587,"startTime":"0","endTime":"0","summary":"四川科伦博泰生物医药股份有限公司于2026年2月4日发布2026年1月股份变动月报表，报告期为2026年1月1日至1月31日。公告显示，公司整体股本结构保持稳定，未见新增发行或购回动作。根据月报表，公司截至2026年1月31日的注册股本总额为人民币233,185,969元，具体包括：H股162,769,979股，内资股65,773,800股，非上市外资股4,642,190股。上述各类已发行股份数量均与上月底相同，库存股份数目为零。本次月报表由联席公司秘书周泽剑签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2608352283","title":"每日沽空追蹤 | 科倫博泰生物-B 02月04日沽空量成交2.89萬股，沽空比例為5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608352283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608352283?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 16:30","pubTimestamp":1770193838,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月04日，涨5.28%，卖空量成交2.89万股，较上一交易日减少62.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163832a47b1127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2608635243","title":"科倫博泰生物-B02月04日獲主力加倉196.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608635243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608635243?lang=zh_tw&edition=fundamental","pubTime":"2026-02-04 16:15","pubTimestamp":1770192943,"startTime":"0","endTime":"0","summary":"02月04日, 科伦博泰生物-B股价涨5.28%，报收422.80元，成交金额2.2亿元，换手率0.33%，振幅8.32%，量比1.07。科伦博泰生物-B今日主力资金净流入196.7万元，连续6日净流入，上一交易日主力净流入264.8万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为71.43%，平均涨幅为2.98%。该股近5个交易日下跌1.27%，主力资金累计净流入2117.8万元；近20日主力资金累计净流出1514.6万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161932a6d1f1a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2608829980","title":"科倫博泰生物-B02月03日獲主力加倉264.8萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608829980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608829980?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 16:15","pubTimestamp":1770106539,"startTime":"0","endTime":"0","summary":"02月03日, 科伦博泰生物-B股价涨0.10%，报收401.60元，成交金额1.7亿元，换手率0.26%，振幅3.59%，量比0.88。科伦博泰生物-B今日主力资金净流入264.8万元，连续5日净流入，上一交易日主力净流入144.8万元。该股近5个交易日下跌1.76%，主力资金累计净流入3011.4万元；近20日主力资金累计净流出4612.4万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161908a476af20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2608186448","title":"醫藥行業跟蹤報告：MNC重金加碼中國創新藥，中國IO2.0雙抗出海邁出關鍵一步","url":"https://stock-news.laohu8.com/highlight/detail?id=2608186448","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608186448?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 18:07","pubTimestamp":1770026824,"startTime":"0","endTime":"0","summary":"投资要点：医药板块行情复盘：本周市场以震荡调整为主，SW医药生物指数下跌3.31%，在申万一级行业指数中排名22/31，跑输沪深300指数；各细分板块中，血液制品、疫苗表现相对较好，主要与尼帕病毒概念相关，部分CXO个股由于业绩催化表现较为突出，线下药店和医院表现较弱。依沃西海外上市申请获美国FDA受理，全球市场拓展迈出关键一步。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202180714a6c9e2ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202180714a6c9e2ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","09606","06990","BK1593","01530","09926","BK1574","BK1583","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2608104688","title":"每日沽空追蹤 | 科倫博泰生物-B 02月02日沽空量成交4.45萬股，沽空比例為8.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608104688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608104688?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 16:30","pubTimestamp":1770021038,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B北京时间02月02日，跌3.42%，卖空量成交4.45万股，较上一交易日减少76.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163833a6c987ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2608450810","title":"百濟神州 ≈ 信達生物+科倫博泰+康方生物 ？","url":"https://stock-news.laohu8.com/highlight/detail?id=2608450810","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608450810?lang=zh_tw&edition=fundamental","pubTime":"2026-02-02 11:29","pubTimestamp":1770002959,"startTime":"0","endTime":"0","summary":"截止到2026年2月2日午间市值数据显示：百济神州以约3070亿港元的市值，几乎等同于信达生物、科伦博泰生物与康方生物三者的总和。2025年第三季度，百济神州净利润达1.25亿美元，而去年同期为亏损1.21亿美元。信达生物、科伦博泰和康方生物则仍处于高增长、高投入阶段，其估值包含了风险溢价和未来成长潜力。对于信达生物、科伦博泰和康方生物而言，未来18-24个月是关键的验证期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202114914a471920b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","HK0000165453.HKD","LU2097828714.EUR","LU2476274720.SGD","BK1588","LU0348766576.USD","LU0455707207.USD","LU0348784397.USD","LU0348827113.USD","IE00B543WZ88.USD","06990","LU2097828557.USD","LU0348767384.USD","LU0417516902.SGD","LU1303224171.USD","BK1589","BK1161","LU1961090484.USD","BK1500","06160","LU1719994722.HKD","LU2328871848.SGD","BK1574","LU1770034418.SGD","LU2399975544.HKD","LU1720050803.USD","01801","LU0561508036.HKD","LU2097828805.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU1794554557.SGD","LU0196878994.USD","LU1969619763.USD","IE00BPRC5H50.USD","LU2097828631.EUR","LU2488822045.USD","LU2242644610.SGD","LU0502904849.HKD","LU0348735423.USD","LU1251922891.USD","LU2097828474.EUR","09926","LU0588546209.SGD","LU0540923850.HKD","LU0348783233.USD","LU0348825331.USD","LU0417516571.SGD","LU2778985437.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}